A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients With Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: renal cancer | Renal Cell Carcinoma | kidney cancer
Age: Between 18 - 100 Years
Gender: Male or Female
In order to be eligible to take part in this trial, patients must meet the following criteria:
- 18 years or older
- Patients with newly diagnosed higher risk RCC of any histology including sarcomatoid
For a full list of participation criteria, please visit clinicaltrials.gov.
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required